Clinical trial NCT06614842: Common Factors Group Psychotherapy for General Mental Health Concerns
Official title: Common Factors Group Psychotherapy for General Mental Health Concerns
Study type: INTERVENTIONAL
Overall status: WITHDRAWN
Phase: NA
Conditions: Major Depression
Generalized Anxiety
Stress Disorder, Post Traumatic
Stress
Mental Disorders
Keywords: common factors psychotherapy
Lead sponsor: University of Alabama at Birmingham
Sponsor class: OTHER
First posted: 2024-09-26
Enrollment: 0
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The current research will investigate the impact of general psychotherapy using common factors (i.e., techniques and communication skills that are common to all major forms of psychotherapy) to investigate whether mental health professionals can treat a variety of mental health concerns utilizing this general form of psychotherapy as opposed to specific forms of psychotherapy that may require specific trainings or education.

Detailed description: The current research will investigate the impact of general psychotherapy using common factors (i.e., techniques and communication skills that are common to all major forms of psychotherapy) to investigate whether mental health professionals can treat a variety of mental health concerns utilizing this general form of psychotherapy as opposed to specific forms of psychotherapy that may require specific trainings or education.

Eligibility criteria: Inclusion Criteria:

* At least 18 years old
* Experiencing self-reported psychological distress

Exclusion Criteria:

* has engaged in self-harm within the last three months
* has attempted suicide within the last year
* has had an active plan to attempt suicide within the last 30 days
* currently diagnosed with any eating disorder
* has experienced hallucinations or delusions within the last 30 days
* has used narcotics within the last 7 days (heroin, meth, crack cocaine, opioids)

Primary outcomes:
measure: Generalized Anxiety Disorder-7 Screener
timeFrame: At enrollment and at the end of treatment at 6 weeks
measure: Patient Health Questionnaire-9 Screener
timeFrame: At enrollment and at the end of treatment at 6 weeks
measure: Patient Checklist-5
timeFrame: At enrollment and at the end of treatment at 6 weeks
measure: Yale-Brown Obsessive Compulsive Scale
timeFrame: At enrollment and at the end of treatment at 6 weeks
measure: Alcohol Use Disorders Identification Test
timeFrame: At enrollment and at the end of treatment at 6 weeks
measure: National Institute of Drug Abuse Modified Alcohol, Smoking, and Substance Involvement Screening Test
timeFrame: At enrollment and at the end of treatment at 6 weeks
Secondary outcomes:
measure: Life Quality Scale
timeFrame: At enrollment and at the end of treatment at 6 weeks
measure: Experiential Avoidance Rating Scale
timeFrame: At enrollment and at the end of treatment at 6 weeks
Other outcomes:
measure: Therapeutic Alliance Scale
timeFrame: At conclusion of therapy after 6 weeks.
Locations:
city: Birmingham
country: United States
facility: University of Alabama at Birmingham
state: Alabama
Study officials:
affiliation: University of Alabama at Birmingham
name: Nicholas Borgogna, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: University of Alabama at Birmingham
name: Drew Whittington, MS, MA
role: PRINCIPAL_INVESTIGATOR
References: